METHODS FOR TREATING ACUTE MYELOID LEUKEMIA AND RELATED CONDITIONS

To provide methods for treating or inhibiting cancer and/or one or more related conditions.SOLUTION: A method for treating acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), neutropenia, or mucositis comprises administering to a subject in need of treatment thereof a fixed dose of 200...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CURT D WOLFGANG, HELEN M THACKRAY, HENRY H FLANNER
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CURT D WOLFGANG
HELEN M THACKRAY
HENRY H FLANNER
description To provide methods for treating or inhibiting cancer and/or one or more related conditions.SOLUTION: A method for treating acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), neutropenia, or mucositis comprises administering to a subject in need of treatment thereof a fixed dose of 200 mg to 4000 mg per day of a compound of Formula (I).SELECTED DRAWING: Figure 15 【課題】がんおよび/または1もしくはそれを超える関連状態を処置または抑制する方法を提供する。【解決手段】急性リンパ性白血病(AML)、骨髄異形成症候群(MDS)、好中球減少症または粘膜炎を処置するための方法であって、AML、MDS、好中球減少症または粘膜炎の処置を必要とする被験体に、1日当たり200mg~4000mgの固定された用量の式(I)の化合物を投与することを含む、方法である。JPEG2023145674000021.jpg52130【選択図】図15
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2023145674A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2023145674A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2023145674A3</originalsourceid><addsrcrecordid>eNrjZHDydQ3x8HcJVnDzD1IICXJ1DPH0c1dwdA4NcVXwjXT18fd0UfBxDfV29fV0VHD0c1EIcvVxDHF1UXD293PxDPH09wvmYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxXgFGBkbGhiamZuYmjsZEKQIATpUrmg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHODS FOR TREATING ACUTE MYELOID LEUKEMIA AND RELATED CONDITIONS</title><source>esp@cenet</source><creator>CURT D WOLFGANG ; HELEN M THACKRAY ; HENRY H FLANNER</creator><creatorcontrib>CURT D WOLFGANG ; HELEN M THACKRAY ; HENRY H FLANNER</creatorcontrib><description>To provide methods for treating or inhibiting cancer and/or one or more related conditions.SOLUTION: A method for treating acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), neutropenia, or mucositis comprises administering to a subject in need of treatment thereof a fixed dose of 200 mg to 4000 mg per day of a compound of Formula (I).SELECTED DRAWING: Figure 15 【課題】がんおよび/または1もしくはそれを超える関連状態を処置または抑制する方法を提供する。【解決手段】急性リンパ性白血病(AML)、骨髄異形成症候群(MDS)、好中球減少症または粘膜炎を処置するための方法であって、AML、MDS、好中球減少症または粘膜炎の処置を必要とする被験体に、1日当たり200mg~4000mgの固定された用量の式(I)の化合物を投与することを含む、方法である。JPEG2023145674000021.jpg52130【選択図】図15</description><language>eng ; jpn</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231011&amp;DB=EPODOC&amp;CC=JP&amp;NR=2023145674A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231011&amp;DB=EPODOC&amp;CC=JP&amp;NR=2023145674A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CURT D WOLFGANG</creatorcontrib><creatorcontrib>HELEN M THACKRAY</creatorcontrib><creatorcontrib>HENRY H FLANNER</creatorcontrib><title>METHODS FOR TREATING ACUTE MYELOID LEUKEMIA AND RELATED CONDITIONS</title><description>To provide methods for treating or inhibiting cancer and/or one or more related conditions.SOLUTION: A method for treating acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), neutropenia, or mucositis comprises administering to a subject in need of treatment thereof a fixed dose of 200 mg to 4000 mg per day of a compound of Formula (I).SELECTED DRAWING: Figure 15 【課題】がんおよび/または1もしくはそれを超える関連状態を処置または抑制する方法を提供する。【解決手段】急性リンパ性白血病(AML)、骨髄異形成症候群(MDS)、好中球減少症または粘膜炎を処置するための方法であって、AML、MDS、好中球減少症または粘膜炎の処置を必要とする被験体に、1日当たり200mg~4000mgの固定された用量の式(I)の化合物を投与することを含む、方法である。JPEG2023145674000021.jpg52130【選択図】図15</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHDydQ3x8HcJVnDzD1IICXJ1DPH0c1dwdA4NcVXwjXT18fd0UfBxDfV29fV0VHD0c1EIcvVxDHF1UXD293PxDPH09wvmYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxXgFGBkbGhiamZuYmjsZEKQIATpUrmg</recordid><startdate>20231011</startdate><enddate>20231011</enddate><creator>CURT D WOLFGANG</creator><creator>HELEN M THACKRAY</creator><creator>HENRY H FLANNER</creator><scope>EVB</scope></search><sort><creationdate>20231011</creationdate><title>METHODS FOR TREATING ACUTE MYELOID LEUKEMIA AND RELATED CONDITIONS</title><author>CURT D WOLFGANG ; HELEN M THACKRAY ; HENRY H FLANNER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2023145674A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CURT D WOLFGANG</creatorcontrib><creatorcontrib>HELEN M THACKRAY</creatorcontrib><creatorcontrib>HENRY H FLANNER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CURT D WOLFGANG</au><au>HELEN M THACKRAY</au><au>HENRY H FLANNER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHODS FOR TREATING ACUTE MYELOID LEUKEMIA AND RELATED CONDITIONS</title><date>2023-10-11</date><risdate>2023</risdate><abstract>To provide methods for treating or inhibiting cancer and/or one or more related conditions.SOLUTION: A method for treating acute myelogenous leukemia (AML), myelodysplastic syndrome (MDS), neutropenia, or mucositis comprises administering to a subject in need of treatment thereof a fixed dose of 200 mg to 4000 mg per day of a compound of Formula (I).SELECTED DRAWING: Figure 15 【課題】がんおよび/または1もしくはそれを超える関連状態を処置または抑制する方法を提供する。【解決手段】急性リンパ性白血病(AML)、骨髄異形成症候群(MDS)、好中球減少症または粘膜炎を処置するための方法であって、AML、MDS、好中球減少症または粘膜炎の処置を必要とする被験体に、1日当たり200mg~4000mgの固定された用量の式(I)の化合物を投与することを含む、方法である。JPEG2023145674000021.jpg52130【選択図】図15</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; jpn
recordid cdi_epo_espacenet_JP2023145674A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title METHODS FOR TREATING ACUTE MYELOID LEUKEMIA AND RELATED CONDITIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T09%3A38%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CURT%20D%20WOLFGANG&rft.date=2023-10-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2023145674A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true